首页> 外文期刊>Pan African Medical Journal >Dysfonction érectile chez les patients diabétiques type 2, prévalence et gravité au service d′urologie du Centre Hospitalier Universitaire de FES (Maroc): à propos de 96 cas (étude transversale)
【24h】

Dysfonction érectile chez les patients diabétiques type 2, prévalence et gravité au service d′urologie du Centre Hospitalier Universitaire de FES (Maroc): à propos de 96 cas (étude transversale)

机译:糖尿病患者的勃起功能障碍2型,FES医院中心(摩洛哥)的泌尿外科服务患病率和重力:约96例(横向研究)

获取原文
       

摘要

Introduction:type 2 diabetes is a very common condition which, in some patients, may cause erectile dysfunction. The purpose of this study is to determine the prevalence and severity of erectile dysfunction in patients with type 2 diabetes attending the Department of Urology.Methods:we conducted a cross-sectional and descriptive study in the Department of Urology at the University Hospital Center Hassan II in Fez using a self-administered questionnaire encompassing an "International Index of Erectile Function-5" test based on 5 questions with routine blood test results in diabetic patients.Results:a total of 96 anonymous questionnaires were distributed over a 12-month period. The average age of patients was 53.5 years, 35% (n=34) of them were active smokers. Diabetes had progressed for over 10 years in 54% (n=52) of cases. Three patients were treated with diet alone, 32% (n=31) with oral antidiabetic drugs, 31% (n=30) with insulin therapy alone and 31% (n=30) with insulin and oral antidiabetic drugs. Only 11% (n=11) of patients had HbA1c below 7%. Patients reporting erectile dysfunction accounted for 70% (n=67) of surveyed patients. The proportion of patients with erectile dysfunction according to the International Index of erectile function-5 was 88% (n=84). The onset of erectile dysfunction had started more than 3 years earlier in 63% (n=60) of patients. Disorders started progressively in 90% (n=86) of patients. Screening rate was 37.5% (n=36), only 30% (n=29) of patients received phosphodiesterase type 5 inhibitors, then intracavernous injection or both. Forty-two per cent (n=40) of patients had either macro or micro-angiopathic complications.Conclusion:erectile dysfunction is a common but little suspected condition in diabetic men. Hence, the importance of systematic screening in any diabetic patient and of adequate treatment for sexual and cardiovascular disorders.Copyright: Mustapha Ahsaini et al.
机译:简介:2型糖尿病是一种非常常见的病症,在一些患者中,可能导致勃起功能障碍。本研究的目的是确定参加泌尿外科的2型糖尿病患者勃起功能障碍的患病率和严重程度。方法:我们在大学医院哈桑二世院校泌尿外科进行横断面和描述性研究在FEZ使用自我管理的调查问卷,基于5个问题,糖尿病患者的常规血液测试结果基于5个问题。结果:在12个月内分发了96个匿名问卷。患者的平均年龄为53.5岁,其中35%(n = 34)是活跃的吸烟者。糖尿病进展超过54%(n = 52)的病例。单独使用饮食治疗三名患者,具有口腔抗糖尿病药物32%(n = 31),31%(n = 30),单独胰岛素治疗,31%(n = 30),具有胰岛素和口服抗糖尿病药物。只有11%(n = 11)的患者的HBA1c低于7%。报告勃起功能障碍的患者占调查患者的70%(n = 67)。根据国际勃起函数-5的国际指标的勃起功能障碍患者的比例为88%(n = 84)。勃起功能障碍的发病在63%(n = 60)的患者中已经开始超过3年。疾病在90%(n = 86)的患者中逐渐开始。筛选率为37.5%(n = 36),仅30%(n = 29)患者接受磷酸二酯酶5型抑制剂,然后内部注射或两者。 42%(n = 40)的患者具有宏观或微血管病疗法并发症。结论:勃起功能障碍是糖尿病男性的常见但很少有疑似病症。因此,系统筛选在任何糖尿病患者和性心血管障碍的充分治疗中的重要性。柔毛:Mustapha Ahsaini等。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号